No abstract available
Keywords:
Anti-PD-1 antibody; Melanoma; Pembrolizumab; Polymyalgia rheumatica.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Melanoma / drug therapy*
-
Melanoma / pathology
-
Neoplasm Invasiveness / pathology
-
Neoplasm Staging
-
Polymyalgia Rheumatica / chemically induced*
-
Polymyalgia Rheumatica / physiopathology
-
Rare Diseases
-
Risk Assessment
-
Sampling Studies
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology
-
Tomography, X-Ray Computed / methods
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
pembrolizumab